Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Pediatric Interventional Cardiology Market Report by Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, and Others), Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, and Others), End Use (Clinical Testing Laboratories, Hospitals, Cardiac Centers, Pediatric Clinics, Research Institutions), and Region 2024-2032
... (Clinical Testing Laboratories, Hospitals, Cardiac Centers, Pediatric Clinics, Research Institutions), and Region 2024-2032 The global pediatric interventional cardiology market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach ... Read More
-
Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024
... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More
-
Untreated Metastatic or Unresectable Melanoma- Pipeline Insight, 2024
... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More
-
Sex Toys
... at a CAGR of 7.8% over the analysis period 2023-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$36.8 Billion by the end of ... Read More
-
Allergy Diagnostics
... at a CAGR of 10.2% over the analysis period 2023-2030. Allergy Diagnostics Assay Kits, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$4.5 Billion by the ... Read More
-
Antidepressants
... of 2.5% over the analysis period 2023-2030. Antidepressants market for Major Depressive Disorder, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$7.0 Billion by the end ... Read More
-
Smoking Cessation and Nicotine De-Addiction Products
... the year 2023, is expected to reach US$54.9 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. E-cigarettes, one of the segments analyzed in the report, is expected to record ... Read More
-
Ophthalmic Pharmaceutical Drugs
... by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Anti-VEGF Agents Drug Class, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$34.3 ... Read More
-
Cardiology IT Workflow Solutions
... reach US$1.8 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach ... Read More
-
Optical Coherence Tomography (OCT) for Ophthalmology
... the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Conventional OCT Systems, one of the segments analyzed in the report, is expected ... Read More
-
Energy-based Therapeutics
... at a CAGR of 3.7% over the analysis period 2023-2030. Laser-based Technology, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.6 Billion by the end of ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
Kidney Dialysis Equipment and Supplies
... is expected to reach US$32.9 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Hemodialysis Equipment and Supplies, one of the segments analyzed in the report, is expected to record ... Read More
-
Neurorehabilitation Devices
... at a CAGR of 16.5% over the analysis period 2023-2030. Neurorobotic Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$2.0 Billion by the end of ... Read More
-
Metabolic Testing Solutions
... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. CPET Systems, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$324.1 Million by ... Read More
-
Dental Preventive Supplies
... by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. The U.S. Market is Estimated at US$151.4 Million While China is Forecast to Grow at 6.4% CAGR The Dental Preventive Supplies market ... Read More
-
Ophthalmic Ultrasound Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
... & Clinics, Ambulatory Surgical Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising cases of various ophthalmic disease such as cataract, vision impairment, and ... Read More
-
Vitreoretinal Surgery Devices Market By Product (Perfluorocarbon Liquids, Endoillumination Instrument, Vitreoretinal Prefilled Silicone Oil Syringes, Vitrectomy System, Other) , By Surgery Type (Anterior Vitreoretinal Surgery, Posterior Vitreoretinal Surgery) By End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... Surgery Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033 Vitreoretinal Surgery Devices The vitreoretinal surgery devices market was valued at $2.3 billion in 2023 and is projected to reach $4.1 billion by 2033, growing ... Read More
-
Narcolepsy Therapeutics
... at a CAGR of 7.2% over the analysis period 2023-2030. Narcolepsy with Cataplexy Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.9 Billion by the ... Read More
-
Orthopedic Devices
... at a CAGR of 6.3% over the analysis period 2023-2030. Joint Reconstruction Devices, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$44.6 Billion by the end ... Read More
-
EEG, EMG and Evoked Potential Devices
... the year 2023, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Electroencephalograph Equipment, one of the segments analyzed in the report, is expected to ... Read More
-
Food Allergy and Intolerance Products
... is expected to reach US$53.9 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Lactose-Free Products, one of the segments analyzed in the report, is expected to record a 5.1% ... Read More
-
Overactive Bladder (OAB) Therapeutics
... reach US$1.5 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. Anticholinergics Therapy, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach ... Read More
-
Bone and Joint Health Supplements
... is expected to reach US$22.0 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Joint Supplements, one of the segments analyzed in the report, is expected to record a 6.3% ... Read More
-
Testosterone Replacement Therapy (TRT)
... reach US$2.5 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. TRT Topicals, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach ... Read More
Research Assistance
